Keyphrases
Human Pancreatic Adenocarcinoma
100%
Carboxyl
100%
Pro-apoptotic Peptide
100%
Pancreatic Adenocarcinoma
85%
Apoptosis
57%
Active caspase-3
42%
Gemcitabine
28%
Radiation Therapy
28%
Pancreas Cancer
28%
Tumor Necrosis Factor-α
14%
Phosphoinositide 3-kinase (PI3K)
14%
Effective Treatment
14%
Recombinant
14%
High Dose
14%
Tumor Cells
14%
Negative Control
14%
Peripheral Blood Mononuclear Cells
14%
Inducer
14%
Allograft
14%
Dose Effect
14%
Phosphatidylinositol
14%
N-terminal Domain
14%
Akt Phosphorylation
14%
Caspase-3
14%
Small Tumor
14%
Cell-penetrating Peptide
14%
Tumor Burden
14%
Xenograft
14%
TUNEL
14%
Tumor Cell Death
14%
Anti-apoptotic
14%
Tissue Type
14%
Wortmannin
14%
Adenocarcinoma Cells
14%
Therapeutic Benefits
14%
Protein Kinase B/Akt
14%
Apoptotic Activity
14%
AKT Pathway
14%
Gemcitabine Chemotherapy
14%
Medicine and Dentistry
Carboxy Terminal Sequence
100%
Pancreas Adenocarcinoma
100%
Protein Kinase B
100%
Protein A
100%
Programmed Cell Death
57%
Caspase 3
57%
Gemcitabine
42%
Tumor Cell
28%
Pancreas Cancer
28%
Radiation Therapy
28%
Tumor Necrosis Factor
14%
Neoplasm
14%
In Vitro
14%
Antiapoptotic
14%
Cell Death
14%
Allograft
14%
Amino Terminal Sequence
14%
Drug Megadose
14%
Cell Line
14%
Phosphotransferase
14%
Peripheral Blood Mononuclear Cell
14%
Xenograft
14%
Single Drug Dose
14%
Tissue (Anatomy)
14%
Phosphatidylinositol
14%
Wortmannin
14%
Pancreatic Adenocarcinoma Cell Line
14%
Effective Treatment
14%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
100%
Protein Kinase B
100%
Protein A
100%
Caspase 3
57%
Neoplasm
42%
Gemcitabine
42%
Pancreas Cancer
28%
Tumor Necrosis Factor
14%
Phosphotransferase
14%
Antiapoptotic
14%
Chemotherapy
14%
Phosphatidylinositol
14%
Wortmannin
14%